Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.41 |
| ▸ | AURKA | O14965 | 1/20 | 0.41 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.41 |
| ▸ | CDK8 | P49336 | 1/20 | 0.41 |
| ▸ | NEK2 | P51955 | 1/20 | 0.41 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.41 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.41 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | MPO | P05164 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9108281 | 0.84 | ESR2 (0.44) | ESR2ALDH1A1LMNAKMT2AMEN1 | |
| SCHEMBL4814314 | 0.81 | ESR2 (0.41) | ESR2MAPTKDM4ERAB9A | |
| SCHEMBL23320542 | 0.81 | CA9 (0.49) | CHEK1AURKACSNK1A1CDK8NEK2 | |
| SCHEMBL5137221 | 0.81 | CHEK1 (0.48) | CHEK1AURKACSNK1A1CDK8NEK2 | |
| SCHEMBL5312199 | 0.80 | ESR2 (0.71) | ESR2ALDH1A1LMNAHTTMAPT | |
| SCHEMBL28792817 | 0.79 | ESR2 (0.74) | ESR2ALDH1A1LMNAHTTMAPT | |
| SCHEMBL9910898 | 0.77 | MAPT (0.40) | CHEK1AURKACSNK1A1CDK8NEK2 | |
| SCHEMBL9910899 | 0.77 | CHEK1 (0.70) | CHEK1AURKACSNK1A1CDK8NEK2 | |
| SCHEMBL16498629 | 0.77 | ESR2 (0.47) | ESR2CHEK1AURKACSNK1A1CDK8 | |
| SCHEMBL9910900 | 0.75 | CHEK1 (0.59) | CHEK1AURKACSNK1A1CDK8NEK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546389-B2 | Viral polymerase inhibitors | BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) | 2013-10-01 | — | — | US | disclosed |
| US-20120142686-A1 | VIRAL POLYMERASE INHIBITORS | BIOTA SCIENTIFIC MANAGEMENT PTY LTD | 2012-06-07 | — | — | US | disclosed |
| WO-2011153588-A1 | VIRAL POLYMERASE INHIBITORS | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2011-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142686-A1 | VIRAL POLYMERASE INHIBITORS | POLR2E, POLM, POLR2H | ESR2 3587/4885CHEK1 3433/4885AURKA 2705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.